Smith, Gregg David,Fida, Rose,Kowalski, Mark Marion
申请号：
AU2011335882
公开号：
AU2011335882B2
申请日:
2011.11.29
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
Described herein is a method for treating a subject experiencing anemia, comprising administering to the subject an amount of N-(cyanomethyl)-4-[2-[[4-(4- morpholinyl)phenyl]amino]-4-pyrimidinyl]-benzamide [CYT387] or a related compound effective to maintain or elevate the hemoglobin level. The anemic subjects including those afflicted with a myeloproliferative disorder, such as primary myelofibrosis.
